Woo, Sungmin https://orcid.org/0000-0001-8459-8369
Araji, Abdallah
El Amine, Mohammad Ali
Gangai, Natalie
Acquafredda, Elizabeth
Price, Anita P.
Trippett, Tanya M.
Hricak, Hedvig
Vargas, Hebert Alberto
Behr, Gerald G.
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
Article History
Received: 11 March 2021
Accepted: 16 August 2021
First Online: 28 August 2021
Declarations
:
: This study received approval (IRB # 19–369) from the institution review board of Memorial Sloan Kettering Cancer Center and was compliant with the Health Insurance Portability and Accountability Act
: Our study was not a case report and the need for informed consent for publication was waived by our institutional IRB due to the noninvasiveness (retrospective analysis of existing data).
: Since May 2017, Dr. Hricak has served on the Board of Directors of Ion Beam Applications (IBA), a publicly traded company, and she receives annual compensation for her service. Furthermore, Dr. Hricak is a member of the External Advisory Board of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (SKCCC), the International Advisory Board of the University of Vienna, Austria, the Scientific Committee of the DKFZ (German Cancer Research Center), Germany, the Board of Trustees the DKFZ (German Cancer Research Center), Germany and a member of the Scientific Advisory Board (SAB) of Euro-BioImaging ERIC; she does not receive financial compensation for any of these roles. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.